Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT02248194
Eligibility Criteria:
Inclusion Criteria:
* Patients with dysfunctional uterine bleeding aged between 40 to 50 years
* Unsuccessful medical treatment.
* No intrauterine abnormalities.
* Endometrial biopsy negative for atypia and cancer.
* follicle stimulating hormone level not exceeds 30 mills-International unit
* Family complete
* Patients who are not candidate for hysterectomy because of medical or surgical risks.
Exclusion Criteria:
* Coexisting gynecological pathology (e.g. uterovaginal prolapsed, ovarian pathology, pelvic inflammatory disease, cervical atypia).
* Endometrial hyperplasia with atypia and cancer..
* History or evidence of malignancy.
* Hyperplasia in the endometrial biopsy.
* Uterine size more than 12 weeks in size.
* Women with caesarean or myomectomy scar
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
40 Years
Maximum Age:
50 Years
Study:
NCT02248194
Study Brief:
Protocol Section:
NCT02248194